Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Weight loss products (3)
- Regulatory compliance (33)
- Therapeutic goods regulation (33)
- Medicine safety (29)
- Prescription medicines (27)
- Vaping hub (19)
- Advertising (16)
- Legislation (15)
- Compliance and enforcement hub (13)
- Safety (12)
- Manufacturing (11)
- Complementary medicines (10)
- Australian Register of Therapeutic Goods (ARTG) (9)
- Non-prescription medicines (9)
- Import and export (8)
- Labelling and packaging (8)
- Listed medicines (8)
- Medical devices safety (8)
- Medicinal cannabis hub (6)
- Over the counter (OTC) medicines (6)
- Alert/Advisory (5)
- COVID-19 vaccines (5)
- Scheduling (national classification system) (5)
- COVID-19 (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Clinical trials (2)
- Advisory bodies and committees (1)
- Assessed listed medicines (1)
- Blood and blood components (1)
- Fees and payments (1)
- Registered complementary medicines (1)
- Shortages (1)
- Sunscreens (1)
Search
3 result(s) found, displaying 1 to 3
-
Media releasesThe TGA reminds businesses and media outlets that it is unlawful to publicly advertise prescription-only medicines, including prescription-only weight loss medicines.
-
Media releasesAmendments to the Therapeutic Goods Regulations 1990 (Schedule 5, item 6) have been made resulting in compounded GLP-1 RA products no longer being able to be compounded by pharmacists and supplied to patients.
-
BlogSome online health clinics are advertising and selling compounded medicines. However, it is important to know that compounded products are not identical to TGA approved products.